Skip to main content
. 2018 Apr 1;9(2):182–191. doi: 10.14336/AD.2017.0307

Table 2.

Patients demographics and clinical characteristics (n=75) according to outcome.

Characteristics Non-Survivors
(N=40)
Survivors
(N=35)
p
Male sex n (%) 22 (55) 17 (48.6) 0.57
Age (years) 70.9±7.26 72±7.9 0.53
MBP 78.4±22.3 89.3±21.8 0.03
Comorbidities n (%)
 Hypertension 24 (60) 21 (60) 1.0
 Diabetes 13 (32.5) 12 (34.3) 0.87
 Dyslipidemia 6 (15) 10 (28.6) 0.15
 Cardiovascular disease 19 (47.5) 16 (45.7) 0.87
 Liver disease 4(10) 0 0.05
 CKD 19 (47.5) 15 (42.8) 0.71
 COPD 12 (34.3) 10 (28.7) 0.02
Baseline creatinine 1.2±0.5 1.0±0.4 0.13
Noradrenaline use n (%) 36 (90) 23 (65.7) 0.01
Mechanical ventilation n (%) 29 (72.5) 20 (57.1) 0.16
Urine output in 24h (ml) 842.6±414.2 912.5±624.3 0.70
Focus n (%): 0.81
 lung 20 (50) 19(54.3)
 urine 11(27.5) 7(20)
APACHE II 19.7±6.6 15.1±6.5 0.009
AKI 28 (70) 15 (42.9) 0.03
KDIGO n (%):
 I 6 (20.7) 8 (53.3) 0.02
 II 7 (25) 4 (26.6)
 III 15 (53.6) 3 (20)
Need for dialysis n (%) 3 (7.5) 2 (5.7) 0.63

Values expressed as mean and standard deviation or median and interquartile range. AKI- acute kidney injury, MBP- Mean Blood Pressure, CKD- chronic kidney disease, COPD: chronic obstructive pulmonary disease